The Atopic March: From Skin to the Airways

Many patients with atopic eczema (AE) would “march” to develop allergic rhinitis (AR) and asthma. Physicians, patients and their families often do not appreciate the significance of these diseases as co-morbidities of atopy. The aim of this study was to evaluate the prevalence and severity of airwa...

Full description

Bibliographic Details
Main Authors: Kam Lun E. Hon, Shuxin Susan Wang, Ting-fan Leung
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2012-03-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/333
id doaj-a89d81f15aa9498a83ac18826864acc6
record_format Article
spelling doaj-a89d81f15aa9498a83ac18826864acc62020-11-25T04:11:45ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492012-03-01111333The Atopic March: From Skin to the AirwaysKam Lun E. Hon0Shuxin Susan Wang1Ting-fan Leung2Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, ChinaDepartment of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, ChinaDepartment of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China Many patients with atopic eczema (AE) would “march” to develop allergic rhinitis (AR) and asthma. Physicians, patients and their families often do not appreciate the significance of these diseases as co-morbidities of atopy. The aim of this study was to evaluate the prevalence and severity of airway atopies in patients with AE. AR and asthma severity were assessed in consecutive AE patients seen at a pediatric dermatology clinic by ARS (allergic rhinitis score) and ACT (asthma control test). Eczema severity (SCORAD and Nottingham Eczema Severity Score: NESS) were recorded. 110 patients with AE and 42 patients without AE were recruited. Allergic rhinitis and asthma were significantly more prevalent in patients with AE [odds ratio for AR was 2.9 (CI:1.3 – 6.5) and for asthma 4.3 (CI: 1.3 – 16.10)]. 23 (45%) of the AE patients with AR reported that they were currently on oral antihistamine whereas none of the non-AE group reported such usage. Both groups reported relatively higher sneezing and nasal congestion scores and low “eye watering” score. Comparing mild with moderate-to-severe AE, there was essentially no  difference between the  prevalence of  allergic rhinitis and  asthma, or severity of symptoms by ARS and ACT, but females reported more severe symptoms of sneezing and itching nose. We conclude that  allergic disorders of airway are very common  among AE  patients independent of the eczema severity. Most of the patients have mild-to-moderate AR and asthma. There is a lot of room for parent/patient education, and childhood eczema may prompt early awareness of these airway co-morbidities of atopy. https://ijaai.tums.ac.ir/index.php/ijaai/article/view/333Allergic rhinitisAsthmaAtopic eczemaNESSQuality of lifeSCORAD
collection DOAJ
language English
format Article
sources DOAJ
author Kam Lun E. Hon
Shuxin Susan Wang
Ting-fan Leung
spellingShingle Kam Lun E. Hon
Shuxin Susan Wang
Ting-fan Leung
The Atopic March: From Skin to the Airways
Iranian Journal of Allergy, Asthma and Immunology
Allergic rhinitis
Asthma
Atopic eczema
NESS
Quality of life
SCORAD
author_facet Kam Lun E. Hon
Shuxin Susan Wang
Ting-fan Leung
author_sort Kam Lun E. Hon
title The Atopic March: From Skin to the Airways
title_short The Atopic March: From Skin to the Airways
title_full The Atopic March: From Skin to the Airways
title_fullStr The Atopic March: From Skin to the Airways
title_full_unstemmed The Atopic March: From Skin to the Airways
title_sort atopic march: from skin to the airways
publisher Tehran University of Medical Sciences
series Iranian Journal of Allergy, Asthma and Immunology
issn 1735-1502
1735-5249
publishDate 2012-03-01
description Many patients with atopic eczema (AE) would “march” to develop allergic rhinitis (AR) and asthma. Physicians, patients and their families often do not appreciate the significance of these diseases as co-morbidities of atopy. The aim of this study was to evaluate the prevalence and severity of airway atopies in patients with AE. AR and asthma severity were assessed in consecutive AE patients seen at a pediatric dermatology clinic by ARS (allergic rhinitis score) and ACT (asthma control test). Eczema severity (SCORAD and Nottingham Eczema Severity Score: NESS) were recorded. 110 patients with AE and 42 patients without AE were recruited. Allergic rhinitis and asthma were significantly more prevalent in patients with AE [odds ratio for AR was 2.9 (CI:1.3 – 6.5) and for asthma 4.3 (CI: 1.3 – 16.10)]. 23 (45%) of the AE patients with AR reported that they were currently on oral antihistamine whereas none of the non-AE group reported such usage. Both groups reported relatively higher sneezing and nasal congestion scores and low “eye watering” score. Comparing mild with moderate-to-severe AE, there was essentially no  difference between the  prevalence of  allergic rhinitis and  asthma, or severity of symptoms by ARS and ACT, but females reported more severe symptoms of sneezing and itching nose. We conclude that  allergic disorders of airway are very common  among AE  patients independent of the eczema severity. Most of the patients have mild-to-moderate AR and asthma. There is a lot of room for parent/patient education, and childhood eczema may prompt early awareness of these airway co-morbidities of atopy.
topic Allergic rhinitis
Asthma
Atopic eczema
NESS
Quality of life
SCORAD
url https://ijaai.tums.ac.ir/index.php/ijaai/article/view/333
work_keys_str_mv AT kamlunehon theatopicmarchfromskintotheairways
AT shuxinsusanwang theatopicmarchfromskintotheairways
AT tingfanleung theatopicmarchfromskintotheairways
AT kamlunehon atopicmarchfromskintotheairways
AT shuxinsusanwang atopicmarchfromskintotheairways
AT tingfanleung atopicmarchfromskintotheairways
_version_ 1724416989767663616